15,225 Shares in Moelis & Company (NYSE:MC) Purchased by New England Research & Management Inc.

New England Research & Management Inc. bought a new stake in Moelis & Company (NYSE:MC - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 15,225 shares of the asset manager's stock, valued at approximately $1,125,000.

Other institutional investors also recently bought and sold shares of the company. Bank of Montreal Can grew its position in shares of Moelis & Company by 2.7% in the 2nd quarter. Bank of Montreal Can now owns 7,181 shares of the asset manager's stock worth $409,000 after buying an additional 192 shares during the last quarter. Xponance Inc. boosted its holdings in Moelis & Company by 10.5% in the second quarter. Xponance Inc. now owns 4,501 shares of the asset manager's stock valued at $256,000 after acquiring an additional 426 shares in the last quarter. The Manufacturers Life Insurance Company increased its position in Moelis & Company by 12.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 54,462 shares of the asset manager's stock valued at $3,097,000 after purchasing an additional 5,954 shares during the period. Algert Global LLC bought a new position in Moelis & Company in the 2nd quarter worth $382,000. Finally, Sanctuary Advisors LLC purchased a new stake in shares of Moelis & Company in the 2nd quarter worth about $554,000. 91.53% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms recently issued reports on MC. UBS Group increased their price target on shares of Moelis & Company from $54.00 to $60.00 and gave the stock a "sell" rating in a research note on Tuesday, October 8th. Morgan Stanley raised Moelis & Company from an "underweight" rating to an "overweight" rating and increased their target price for the stock from $66.00 to $92.00 in a research report on Monday, December 9th. Wells Fargo & Company dropped their price target on Moelis & Company from $78.00 to $77.00 and set an "equal weight" rating on the stock in a research report on Tuesday, January 14th. Finally, Keefe, Bruyette & Woods upgraded Moelis & Company from a "market perform" rating to an "outperform" rating and increased their price objective for the stock from $71.00 to $86.00 in a report on Friday, December 20th. One analyst has rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat, Moelis & Company currently has a consensus rating of "Hold" and an average price target of $70.67.

Moelis & Company Trading Up 1.4 %

Moelis & Company stock traded up $1.11 during mid-day trading on Thursday, hitting $78.47. The company had a trading volume of 150,195 shares, compared to its average volume of 669,788. The stock's 50 day moving average price is $75.18 and its two-hundred day moving average price is $70.22. The company has a market capitalization of $5.88 billion, a PE ratio of 148.17 and a beta of 1.39. Moelis & Company has a 12 month low of $46.24 and a 12 month high of $81.60.

Moelis & Company Profile

Moelis & Company operates as an investment banking advisory firm. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic, capital structure, and private funds advisory.